Clinical Trial Update: Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 trial evaluating the combination of docetaxel, doxorubicin, and cyclophosphamide for women with stage III breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxotere (docetaxel)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED